The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help both organizations identify models that may enhance and expand access to medicines and healthcare services for the working poor in China.
The Pfizer and PlaNet Finance collaboration is designed to solicit additional information from low-income populations in China to complement existing and planned government efforts to improve healthcare.
Pfizer and PlaNet Finance look forward to sharing the results of this research with the Chinese government, in order to maximize its impact and reach throughout the country.
Jean-Michel Halfon, president and general manager of emerging markets business unit at Pfizer, said: “Pfizer’s partnership with PlaNet Finance is aligned with the strategy to expand our geographic reach across China. I am extremely confident that this partnership will also achieve the broader aim of identifying unique and workable solutions for the diverse medical needs of patients in emerging markets.”